» Articles » PMID: 34504362

Dual Antiepileptics Induced Stevens-Johnson Syndrome: A Case Report

Overview
Specialty General Medicine
Date 2021 Sep 10
PMID 34504362
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis are acute mucocutaneous reactions hallmark of which is widespread necrosis and detachment of epidermis. SJS/TEN fall under the single disease spectrum with an incidence rate of 1.0 to 6.0 per 1000000 and 0.4 to 1.2 per 1000000 respectively. Here, we present a case of a 46 years female who developed a generalized erythematous rash over her body, 26 days after being exposed to phenytoin and sodium valproate. Given the strong association between SJS and antiepileptic drugs, and the usual presentation being within the first eight weeks of exposure to susceptible medications; we diagnosed her with SJS. Phenytoin and sodium valproate was withdrawn and she was managed with antihistamines and corticosteroids. She improved significantly within 15 days of our intervention. The mortality rates for SJS and TEN are up to 10% and 30-50% respectively. Early identification of SJS, discontinuation of triggering medicines, and prompt initiation of supportive therapy improve the prognosis. Keywords: adverse drug reactions;antiepileptic drugs;case report;stevens-johnson syndrome.

Citing Articles

A Singular Case Analysis: Lamotrigine-Associated Stevens-Johnson Syndrome.

Joshi A, Palikhe A, Acharya S, Kunwor P Case Rep Crit Care. 2024; 2024:4835223.

PMID: 39628963 PMC: 11614506. DOI: 10.1155/crcc/4835223.


Letter to Editor on Dual Anti-Epileptics Induced Stevens-Johnson Syndrome: A Case Report.

Paudel V JNMA J Nepal Med Assoc. 2024; 62(275):483-484.

PMID: 39369414 PMC: 11455632. DOI: 10.31729/jnma.8661.


Stevens-Johnson Syndrome Induced by Herbal Kadha.

Lamture Sr V, Lamture Sr Y, Uke Sr P Cureus. 2023; 15(7):e42407.

PMID: 37637620 PMC: 10447633. DOI: 10.7759/cureus.42407.

References
1.
De Luca F, Losappio L, Mirone C, Schroeder J, Citterio A, Aversano M . Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature. Clin Mol Allergy. 2017; 15:16. PMC: 5627447. DOI: 10.1186/s12948-017-0072-5. View

2.
Avinash A, Amberkar V, Kunder S, Madhyastha S, Meenakumari K . Carbamazepine-induced Life-threatening Stevens-Johnson Syndrome and Agranulocytosis: The Maiden Case. J Clin Diagn Res. 2017; 10(12):FD01-FD03. PMC: 5296452. DOI: 10.7860/JCDR/2016/23748.9065. View

3.
Frey N, Bodmer M, Bircher A, Ruegg S, Jick S, Meier C . The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs. Epilepsia. 2017; 58(12):2178-2185. DOI: 10.1111/epi.13925. View

4.
Dodiuk-Gad R, Chung W, Valeyrie-Allanore L, Shear N . Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update. Am J Clin Dermatol. 2015; 16(6):475-93. DOI: 10.1007/s40257-015-0158-0. View

5.
Duong T, Valeyrie-Allanore L, Wolkenstein P, Chosidow O . Severe cutaneous adverse reactions to drugs. Lancet. 2017; 390(10106):1996-2011. DOI: 10.1016/S0140-6736(16)30378-6. View